ACS Applied Materials & Interfaces · 2024 · 13 citations · 40 references
MedicineOncologyPharmacologyDrug DeliveryEndocytosisMolecular OncologyCancer NanomedicineMagnetic-responsive Drug DeliveryNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignOvarian CancerCancer NanotherapyExtracellular Vesicle TherapyExtracellular VesiclesFenton ReactionIron Oxide NanoparticlesMagnetic GuidanceMagnetic Nanoparticle Drug CarriersMagnetic Oxide Nanoparticles
Chemodynamic therapy (CDT), employing metal ions to transform endogenous H 2 O 2 into lethal hydroxyl radicals ( • OH), has emerged as an effective approach for tumor treatment. Yet, its efficacy is diminished by glutathione (GSH), commonly overexpressed in tumors. Herein, a breakthrough strategy involving extracellular vesicle (EV) mimetic nanovesicles (NVs) encapsulating iron oxide nanoparticles (IONPs) and β-Lapachone (Lapa) was developed to amplify intracellular oxidative stress. The combination, NV-IONP-Lapa, created through a serial extrusion from ovarian epithelial cells showed excellent biocompatibility and leveraged magnetic guidance to enhance endocytosis in ovarian cancer cells, resulting in selective H 2 O 2 generation through Lapa catalysis by NADPH quinone oxidoreductase 1 (NQO1). Meanwhile, the iron released from IONPs ionization under acidic conditions triggered the conversion of H 2 O 2 into • OH by the Fenton reaction. Additionally, the catalysis process of Lapa eliminated GSH in tumor, further amplifying oxidative stress. The designed NV-IONP-Lapa demonstrated exceptional tumor targeting, facilitating MR imaging, and enhanced tumor suppression without significant side effects. This study presents a promising NV-based drug delivery system for exploiting CDT against NQO1-overexpressing tumors by augmenting intratumoral oxidative stress.
40
Tumor-selective catalytic nanomedicine by nanocatalyst delivery
Minfeng Huo, Liying Wang, Yu Chen et al. · Nature Communications · 2017 · 1.3K citations · Full text